Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Revenue from Related Parties

1.5 / 5 stars · 27/93 Roast Me

VYOME HOLDINGS, INC. Revenue from Related Parties

VYOME HOLDINGS, INC. (HIND) reported Revenue from Related Parties of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-05.

Discontinued › Income Statement › Other Income

us-gaap:RevenueFromRelatedParties · last filed 2018-03-05

  • VYOME HOLDINGS, INC. revenue from related parties for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
  • VYOME HOLDINGS, INC. revenue from related parties for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
  • VYOME HOLDINGS, INC. revenue from related parties for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
  • VYOME HOLDINGS, INC. revenue from related parties for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
  • VYOME HOLDINGS, INC. revenue from related parties for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
  • VYOME HOLDINGS, INC. revenue from related parties for fiscal 2016 was $3.39M, a 11.25% decline from fiscal 2015.
  • VYOME HOLDINGS, INC. revenue from related parties for fiscal 2015 was $3.82M, a 105.98% increase from fiscal 2014.
  • VYOME HOLDINGS, INC. revenue from related parties for fiscal 2014 was $1.86M.
Period endRevenue from Related Parties 3 monthRevenue from Related Parties 6 monthRevenue from Related Parties 9 monthRevenue from Related Parties 12 month
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$0.00
derived: sum of 2 quarters · filed 2018-03-05
$0.00
derived: sum of 3 quarters · filed 2018-03-05
$0.00
10-K · filed 2018-03-05
2017-09-30$0.00
10-Q · filed 2017-11-03
$0.00
derived: sum of 2 quarters · filed 2017-11-03
$0.00
10-Q · filed 2017-11-03
$772.00K
derived: sum of 4 quarters · filed 2018-03-05
2017-06-30$0.00
10-Q · filed 2017-08-02
$0.00
10-Q · filed 2017-08-02
$772.00K
derived: sum of 3 quarters · filed 2018-03-05
$1.54M
derived: sum of 4 quarters · filed 2018-03-05
2017-03-31$0.00
10-Q · filed 2017-05-10
$772.00K
derived: sum of 2 quarters · filed 2018-03-05
$1.54M
derived: sum of 3 quarters · filed 2018-03-05
$2.32M
derived: sum of 4 quarters · filed 2018-03-05
2016-12-31$772.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$1.54M
derived: sum of 2 quarters · filed 2018-03-05
$2.32M
derived: sum of 3 quarters · filed 2018-03-05
$3.39M
10-K · filed 2018-03-05
2016-09-30$773.00K
10-Q · filed 2017-11-03
$1.55M
derived: sum of 2 quarters · filed 2017-11-03
$2.62M
10-Q · filed 2017-11-03
$3.61M
derived: sum of 4 quarters · filed 2018-03-05
2016-06-30$779.00K
10-Q · filed 2017-08-02
$1.85M
10-Q · filed 2017-08-02
$2.84M
derived: sum of 3 quarters · filed 2018-03-05
$3.93M
derived: sum of 4 quarters · filed 2018-03-05
2016-03-31$1.07M
10-Q · filed 2017-05-10
$2.06M
derived: sum of 2 quarters · filed 2018-03-05
$3.15M
derived: sum of 3 quarters · filed 2018-03-05
2015-12-31$991.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$2.08M
derived: sum of 2 quarters · filed 2018-03-05
$3.82M
10-K · filed 2018-03-05
2015-09-30$1.09M
10-Q · filed 2016-11-10
$2.83M
10-Q · filed 2016-11-10
2014-12-31$1.86M
10-K · filed 2017-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36